Hypokalemia News and Research

RSS
AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

Triad alcohol prep pads with ARIXTRA Starter Kits not to be used

Triad alcohol prep pads with ARIXTRA Starter Kits not to be used

FDA approves Novartis' Amturnide for treatment of high blood pressure

FDA approves Novartis' Amturnide for treatment of high blood pressure

Patients with chronic constipation prefer Kristalose oral solution

Patients with chronic constipation prefer Kristalose oral solution

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

SPRYCEL receives FDA approval for treating adult patients with Ph+ CML in chronic phase

SPRYCEL receives FDA approval for treating adult patients with Ph+ CML in chronic phase

Strativa enters amended agreement with Sobi for Nascobal Vitamin B12 Nasal Spray

Strativa enters amended agreement with Sobi for Nascobal Vitamin B12 Nasal Spray

COU-AA-301 Phase 3 study demonstrates improvement in CRPC survival rate

COU-AA-301 Phase 3 study demonstrates improvement in CRPC survival rate

Amneal Pharmaceuticals receives FDA approval for Spironolactone HCl tablets

Amneal Pharmaceuticals receives FDA approval for Spironolactone HCl tablets

Tasigna receives approval for chronic myeloid leukemia in Canada

Tasigna receives approval for chronic myeloid leukemia in Canada

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

Pfizer to discontinue commercial availability of Mylotarg for AML in U.S.

Pfizer to discontinue commercial availability of Mylotarg for AML in U.S.

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Clinical trials of four investigational compounds in solid tumors presented at ASCO Annual Meeting

Clinical trials of four investigational compounds in solid tumors presented at ASCO Annual Meeting

Phase 2 Study: NKTR-102 holds great therapeutic potential for women with platinum-resistant/refractory ovarian cancer

Phase 2 Study: NKTR-102 holds great therapeutic potential for women with platinum-resistant/refractory ovarian cancer